ROIV

#579
Roivant Sciences Ltd. Common Shares
29.1200 USD
+0.59%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
29.1200
29.1200
Jahresspanne
18.2700
30.3300
Tagesänderung
+0.59%
Monatliche Änderung
+2.19%
6 month change
+59.04%
Jahresänderung
+59.04%
Vorheriger Schlusskurs
28.9500
Eröffnung
29.1200
Bid
Ask
Tief
29.1200
High
29.1200
Volumen
171
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 2020202120222023 TTM

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Nachrichten